Edward M. Barnett, MD, PhD

Professor of Ophthalmology and Visual Sciences

Locations

The Eye Institute
The Eye Institute
925 N. 87th St.
Milwaukee, WI 53226

Westbrook Health Center
2315 E. Moreland Blvd.
Waukesha, WI 53186

Contact Information

(414) 955-2020

Biography

Honors and Awards

1987 Phi Beta Kappa
1991 Alpha Omega Alpha Honor Medical Society
2006-2013 America’s Top Ophthalmologists – Consumer’s Research Council of America
2011-2014 Best Doctors in America
2001 Diplomate, American Board of Ophthalmology
2010 ABO Maintenance of Certification
American Academy of Ophthalmology (AAO)
American Glaucoma Society (AGS)

Education

MD, University of Iowa College of Medicine, Iowa City, IA, 1995
PhD, Neuroscience, University of Iowa, Iowa City, IA, 1995

Postgraduate Training
Internship, St. Luke’s Medical Center, Milwaukee, WI, 1996
Residency, Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City, IA, 1999
Fellowship, Glaucoma, Washington University Department of Ophthalmology and Visual Sciences, St. Louis, MO, 2000

Optic nerve diffusion tensor imaging parameters and their correlation with optic disc topography and disease severity in adult glaucoma patients and controls.

(Chang ST, Xu J, Trinkaus K, Pekmezci M, Arthur SN, Song SK, Barnett EM.) J Glaucoma. 2014 Oct-Nov;23(8):513-20.
Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.

(Qiu X, Johnson JR, Wilson BS, Gammon ST, Piwnica-Worms D, Barnett EM.) PLoS One. 2014;9(2):e88855.
Caspase-activated cell-penetrating peptides reveal temporal coupling between endosomal release and apoptosis in an RGC-5 cell model.

(Johnson JR, Kocher B, Barnett EM, Marasa J, Piwnica-Worms D.) Bioconjug Chem. 2012 Sep 19;23(9):1783-93.
The incidence of retinal vein occlusion in the ocular hypertension treatment study.

(Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO, Ocular Hypertension Treatment Study Group.) Ophthalmology. 2010 Mar;117(3):484-8.
VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans.

(Fujikawa K, Iwata T, Inoue K, Akahori M, Kadotani H, Fukaya M, Watanabe M, Chang Q, Barnett EM, Swat W.) PLoS One. 2010 Feb 04;5(2):e9050.
Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model.

(Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D.) Proc Natl Acad Sci U S A. 2009 Jun 09;106(23):9391-6.
An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging.

(Maxwell D, Chang Q, Zhang X, Barnett EM, Piwnica-Worms D.) Bioconjug Chem. 2009 Apr;20(4):702-9.
Aqueous humor sCD44 concentration and visual field loss in primary open-angle glaucoma.

(Nolan MJ, Giovingo MC, Miller AM, Wertz RD, Ritch R, Liebmann JM, Allingham RR, Herndon LW, Wax MB, Smolyak R, Hasan F, Barnett EM, Samples JR, Knepper PA.) J Glaucoma. 2007 Aug;16(5):419-29.
Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models.

(Barnett EM, Elangovan B, Bullok KE, Piwnica-Worms D.) Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2589-95.
Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery.

(Camras CB, Toris CB, Sjoquist B, Milleson M, Thorngren JO, Hejkal TW, Patel N, Barnett EM, Smolyak R, Hasan SF, Hellman C, Meza JL, Wax MB, Stjernschantz J.) Ophthalmology. 2004 Dec;111(12):2193-8.
Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease.

(Pewe L, Wu GF, Barnett EM, Castro RF, Perlman S.) Immunity. 1996 Sep;5(3):253-62.
Anterograde tracing of trigeminal afferent pathways from the murine tooth pulp to cortex using herpes simplex virus type 1.

(Barnett EM, Evans GD, Sun N, Perlman S, Cassell MD.) J Neurosci. 1995 Apr;15(4):2972-84.

Edward M. Barnett, MD, PhD